Schedule II controlled substance
GPTKB entity
Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
controlled substance classification
|
| gptkbp:abusePotential |
high
|
| gptkbp:countryOfOrigin |
gptkb:United_States
|
| gptkbp:example |
gptkb:oxycodone
gptkb:morphine gptkb:hydromorphone gptkb:secobarbital gptkb:meperidine gptkb:methylphenidate cocaine amphetamine fentanyl |
| gptkbp:hasAcceptedMedicalUse |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule II controlled substance
|
| gptkbp:prescriptionRequired |
yes
|
| gptkbp:refillsAllowed |
no
|
| gptkbp:regulates |
gptkb:Drug_Enforcement_Administration
gptkb:Controlled_Substances_Act |
| gptkbp:riskOfDependence |
high
|
| gptkbp:scheduleNumber |
II
|
| gptkbp:bfsParent |
gptkb:Oxycodone
gptkb:Secobarbital gptkb:levorphanol gptkb:extended-release_capsule_(Adderall_XR) gptkb:oxymorphone gptkb:Adzenys_XR-ODT gptkb:Dynavel_XR gptkb:Kadian gptkb:Aptensio_XR |
| gptkbp:bfsLayer |
7
|